"Prolonged grief disorder" and "persistent complex bereavement disorder", but not "complicated grief", are one and the same diagnostic entity: an analysis of data from the Yale Bereavement Study by Maciejewski, Paul K et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
”Prolonged grief disorder” and ”persistent complex bereavement disorder”,
but not ”complicated grief”, are one and the same diagnostic entity: an
analysis of data from the Yale Bereavement Study
Maciejewski, Paul K; Maercker, Andreas; Boelen, Paul A; Prigerson, Holly G
Abstract: There exists a general consensus that prolonged grief disorder (PGD), or some variant of PGD,
represents a distinct mental disorder worthy of diagnosis and treatment. Nevertheless, confusion remains
over whether different names and proposed symptom criteria for this disorder identify the same or different
diagnostic entities. This study aimed to determine whether PGD, complicated grief (CG), and persistent
complex bereavement disorder (PCBD) as described by the DSM-5 are substantively or merely seman-
tically different diagnostic entities. Data were derived from the Yale Bereavement Study, a longitudinal
community-based study of bereaved individuals funded by the US National Institute of Mental Health,
designed explicitly to evaluate diagnostic criteria for disordered grief. The results suggested that the
difference between PGD and PCBD is only semantic. The level of agreement between the original PGD
test, a new version of the PGD test proposed for ICD-11 and the PCBD test was high (pairwise kappa
coefficients = 0.80-0.84). Their estimates of rate of disorder in this community sample were similarly
low (￿10%). Their levels of diagnostic specificity were comparably high (95.0-98.3%). Their predictive
validity was comparable. In contrast, the test for CG had only moderate agreement with those for PGD
and PCBD; its estimate of rate of disorder was three-fold higher (￿30%); its diagnostic specificity was
poorer, and it had no predictive validity. We conclude that PGD, PCBD and proposed ICD-11, but not
CG, symptom-diagnostic tests identify a single diagnostic entity. Ultimately, brief symptom-diagnostic
tests, such as the one proposed here for ICD-11, may have the greatest clinical utility.
DOI: 10.1002/wps.20348
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-127068
Published Version
Originally published at:
Maciejewski, Paul K; Maercker, Andreas; Boelen, Paul A; Prigerson, Holly G (2016). ”Prolonged grief dis-
order” and ”persistent complex bereavement disorder”, but not ”complicated grief”, are one and the same
diagnostic entity: an analysis of data from the Yale Bereavement Study. World Psychiatry, 15(3):266-275.
DOI: 10.1002/wps.20348
“Prolonged grief disorder” and “persistent complex bereavement
disorder”, but not “complicated grief”, are one and the same
diagnostic entity: an analysis of data from the Yale
Bereavement Study
Paul K. Maciejewski1-3, Andreas Maercker4, Paul A. Boelen5,6, Holly G. Prigerson1,3
1Center for Research on End-of-Life Care, Weill Cornell Medicine, New York, NY, USA; 2Department of Radiology, Weill Cornell Medicine, New York, NY, USA; 3Depart-
ment of Medicine, Weill Cornell Medicine, New York, NY, USA; 4Department of Psychology, Division of Psychopathology, University of Zurich, Switzerland; 5Department of
Clinical Psychology, Utrecht University, Utrecht, The Netherlands; 6Arq Psychotrauma Expert Group, Diemen, The Netherlands
There exists a general consensus that prolonged grief disorder (PGD), or some variant of PGD, represents a distinct mental disorder worthy of
diagnosis and treatment. Nevertheless, confusion remains over whether different names and proposed symptom criteria for this disorder iden-
tify the same or different diagnostic entities. This study aimed to determine whether PGD, complicated grief (CG), and persistent complex
bereavement disorder (PCBD) as described by the DSM-5 are substantively or merely semantically different diagnostic entities. Data were
derived from the Yale Bereavement Study, a longitudinal community-based study of bereaved individuals funded by the US National Institute
of Mental Health, designed explicitly to evaluate diagnostic criteria for disordered grief. The results suggested that the difference between PGD
and PCBD is only semantic. The level of agreement between the original PGD test, a new version of the PGD test proposed for ICD-11 and the
PCBD test was high (pairwise kappa coefficients5 0.80-0.84). Their estimates of rate of disorder in this community sample were similarly low
(10%). Their levels of diagnostic specificity were comparably high (95.0-98.3%). Their predictive validity was comparable. In contrast, the test
for CG had only moderate agreement with those for PGD and PCBD; its estimate of rate of disorder was three-fold higher (30%); its diagnos-
tic specificity was poorer, and it had no predictive validity. We conclude that PGD, PCBD and proposed ICD-11, but not CG, symptom-
diagnostic tests identify a single diagnostic entity. Ultimately, brief symptom-diagnostic tests, such as the one proposed here for ICD-11, may
have the greatest clinical utility.
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Over the past two decades, there has been increasing aware-
ness and conclusive research demonstrating that prolonged grief
disorder (PGD)1 – intense, prolonged symptoms of grief, cou-
pled with some form of functional impairment beyond 6
months post-loss – constitutes a distinct mental disorder.
Numerous studies have demonstrated that symptoms of grief
are distinct from symptoms of depression and anxiety2-7; that
PGD is distinct from other mental disorders, including major
depressive disorder, generalized anxiety disorder and post-
traumatic stress disorder1,8,9; and that PGD, independent of
other mental disorders, is associated with significant suffering
and enduring functional impairments1,3,9-11.
In light of extensive, convincing evidence in support of PGD
as a new diagnostic category, the World Health Organization
(WHO) has moved to introduce PGD, and the American Psy-
chiatric Association has moved to introduce what appears to
be a version of PGD, into their respective diagnostic classifica-
tion systems (ICD-11 and DSM-5). However, despite these
advances, and perhaps due to lack of unanimity in terminolo-
gy and conceptualization of the disorder, there continues to be
confusion about PGD and its relationships to normative grief
and to other mental disorders.
In recent years, competing characterizations and symptom-
diagnostic tests have been proposed for what would appear to
be a single disorder of grief. The primary opposition has been
between the notion of “prolonged grief disorder”, introduced
by Prigerson et al1 and proposed for adoption in a shortened
version by the ICD-1112,13, and the notion of “complicated
grief” (CG), which has historical roots in the concept of
depression as a bereavement-related “complication”14 and has
been reproposed by Shear et al15. Presented with these two
main alternatives, the DSM-516 introduced yet a third diagnos-
tic concept, i.e. “persistent complex bereavement disorder”
(PCBD), that appears a compromise between “prolonged” and
“complicated” grief. It is unclear whether DSM-5’s PCBD is
essentially PGD, CG or another diagnostic entity altogether.
Semantic differences between PGD, CG and PCBD hinge on
the response to the central question: “is all grief normal?”.
For proponents of PGD, the answer to this question is: “no,
not all grief is normal; in particular, prolonged, unresolved,
intense grief is not normal”. From the PGD perspective, grief
symptoms in themselves are neither atypical nor pathological.
PGD is characterized by normal symptoms of grief that remain
too intense for too long. That is, all symptoms of grief are nor-
mal, but some combination of their severity and their duration
is not. For PGD, the pathology is in the time course of the
symptoms, not in the symptoms per se.
For proponents of CG, the answer to the question is: “yes, all
grief is normal; but, there are complications (mental disorders)
in bereavement aside from grief that merit clinical attention”.
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From this perspective, neither symptoms nor processes of grief
are ever intrinsically pathological17. For CG, the pathology is
attributed to factors other than grief, e.g. bereavement-related
depression or trauma, that interfere with otherwise normal grief
processes.
The DSM-5 designation “persistent complex bereavement
disorder” omits the term “grief” altogether, which avoids
pathologizing any form of grief and thereby leaves safe the
assumption that all grief is normal. The assertion that the
course of grief, in itself, can be pathological in some instances,
i.e., that some grieving processes are inherently abnormal,
separates PGD from both CG and PCBD.
Despite semantic differences, the proposed symptom-
diagnostic tests for PGD, CG and PCBD may point to a single
underlying diagnostic entity. The items included in these tests
are almost entirely derived from a common set of instruments,
i.e., the Inventory of Complicated Grief (ICG)18 and its revi-
sions. There is considerable evidence that items in these instru-
ments represent a unidimensional underlying construct1,18,19.
Nevertheless, the items in each diagnostic formulation consti-
tute unique criteria sets. There may be substantive differences
between symptom-diagnostic tests for PGD, CG and PCBD that
pose the risk of diluting the assessment of what is, at its core, a
pure grief construct.
To date, only the original symptom-diagnostic test for PGD
has been validated empirically. In a US National Institute of
Mental Health (NIMH)-funded study designed explicitly to
evaluate diagnostic criteria for disordered grief, with data col-
lected in a community-based sample (which is essential for
distinguishing between normal and pathological grief reac-
tions), Prigerson et al1 established the construct validity, diag-
nostic sensitivity and specificity, and predictive validity of
diagnostic criteria for PGD.
In contrast, Shear et al introduced the proposed test for CG
in a review article15, without an empirical evaluation or valida-
tion. The proposed test for CG, which includes multiple items
not included in the ICG, was informed by a post-hoc analysis
of ICG data20 collected in highly comorbid, treatment-seeking,
patient samples, ill-suited for drawing distinctions between
normal and pathological grief, recruited for studies that were
not designed for the purpose of evaluating diagnostic criteria
for CG.
The symptom-diagnostic test for PCBD is proposed in an
appendix to DSM-516. The proposed ICD-11 characterization
of PGD presents its core diagnostic features13, but the symp-
toms included in this narrative proposal have yet to be
reduced explicitly to a symptom-diagnostic test, i.e., there is
no specification of how many of these symptoms need to be
present to satisfy the symptom criterion.
In the present investigation, we aimed to compare pro-
posed symptom-diagnostic tests for PGD (both the original
version1 and a new one consistent with the core diagnostic
features of PGD as proposed for ICD-1113), for CG15 and for
PCBD16. We restricted our focus to an examination of tests for
meeting the symptom criterion for grief disorder, as opposed
to the time from loss and impairment criteria, because of the
central role that the symptom criterion plays in the conceptu-
alization, definition and recognition of the disorder.
Given legitimate concerns about pathologizing normal grief
reactions, we prioritized diagnostic specificity above diagnos-
tic sensitivity, favoring tests that minimize “false positives”
(i.e., normal grief reactions diagnosed as mental illness) and
thereby reduce the likelihood of over-diagnosis and over-
treatment. Furthermore, since short tests and simple algo-
rithms are preferred in clinical practice21,22 and lead to higher
reliabilities in routine care23, we considered the brevity and
simplicity of each symptom-diagnostic test for grief disorder
to be indicative of its potential ease of use and clinical utility.
METHODS
Study sample
Data were obtained from the Yale Bereavement Study (YBS),
a NIMH-funded investigation designed to evaluate consensus
criteria24 for disordered grief. The YBS was a longitudinal,
interview-based study of community-dwelling bereaved indi-
viduals. It was approved by the institutional review boards of all
participating sites. Written informed consent was obtained
from all study participants. Interviews were conducted by mas-
ter’s degree-level interviewers trained by YBS investigators.
Interviewers were required to demonstrate nearly perfect agree-
ment (kappa 0.90) with the YBS investigators for diagnoses of
psychiatric disorders and PGD in five pilot interviews before
being permitted to interview for the study. The YBS study is
described in greater detail elsewhere1.
YBS participants (N5317) completed an initial baseline
interview at an average of 6.36 7.0 months post-loss; first
follow-up interviews (N5296, 93.4% of participants) at an
average of 10.96 6.1 months post-loss; and second follow-up
interviews (N5263, 83.0% of participants) at an average of
19.76 5.8 months post-loss. For analysis, data were restruc-
tured into more uniform time periods (0-6 months, 6-12
months, and 12-24 months post-loss).
The average age of participants was 61.86 18.7 years. The
majority of participants were female (73.7%), white (95.3%),
educated beyond high school (60.4%), and spouses of the
deceased (83.9%).
The present study sample (N5268; 84.5% of YBS partici-
pants) included participants interviewed at least once within
6-12 months post-loss and who provided sufficient informa-
tion to evaluate PGD, CG, PCBD and proposed ICD-11 tests for
grief or bereavement disorder.
Grief symptoms (items)
Grief and bereavement-related symptoms (items) were
assessed with the rater-version of the Inventory of Complicated
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Grief - Revised (ICG-R)25, a structured interview designed to
assess a wide variety of potential grief and bereavement-related
symptoms, using five-point scales to represent increasing levels
of symptom severity.
The ICG-R is a modification of the ICG18 that includes all
the symptoms proposed by the consensus panel24 and addi-
tional symptoms enabling the testing of alternative diagnostic
algorithms26.
The ICG-R and the original ICG have proven to be reliable
and valid18,25. Based on prior work24,25, a symptom was con-
sidered present if rated “4” or “5”, and absent if rated “1”, “2”
or “3” on its five-point scale.
Symptom-diagnostic tests
The focus of the present investigation is restricted to symptom-
diagnostic tests for grief disorder (and not other tests or crite-
ria for disorder, e.g. timing or impairment criteria).
Each of the tests under examination has two components,
one including items that capture the essence of the syndrome
(hereafter, referred to as “category A” items) and another
including items that collectively capture the severity of the
syndrome (hereafter, referred to as “category B” items).
Each of the tests described below was assessed at 6-12
months post-loss.
Prolonged grief disorder (PGD) test
The PGD symptom-diagnostic test examined here is identi-
cal to the one introduced by Prigerson et al1. It includes eleven
items represented directly in the ICG-R. A positive test indi-
cates endorsement of at least one of two category A items and
at least five of nine category B items.
Complicated grief (CG) test
Formally, the proposed CG symptom-diagnostic test15 con-
sists of twelve (four category A and eight category B) items.
However, several of these items contain multiple elements and
therefore could be met in multiple ways. For example, the item
“experiencing intense emotional or physiological reactivity to
memories of the person who died or to reminders of the loss”
could be met four ways, yet it is presented as a single item.
Nine of the twelve CG test items can be, and were, repre-
sented directly by one or more ICG-R items. Two CG test
items, i.e. “troubling rumination” and “emotional or physio-
logical reactivity”, can be, and were, approximated by ICG-R
items. The CG test “troubling rumination” item (i.e., “frequent
troubling rumination about circumstances or consequences of
the death, such as concerns about how or why the person died
or about not being able to manage without their loved one,
thoughts of having let the deceased person down, and others”)
was approximated by the ICG-R “preoccupation” item (i.e.,
“do you ever have trouble doing the things you normally do
because you are thinking about [the person who died] so
much?”). The CG test “emotional or physiological reactivity”
item (i.e., “experiencing intense emotional or physiological
reactivity to memories of the person who died or to reminders
of the loss”) was approximated by the ICG-R “memories upset
you” item (i.e., “do memories of [the person who died] ever
upset you?”). One CG test item contained an element of survi-
vor guilt, which can be, and was, represented directly by the
ICG-R “survivor guilt” item, and an element of suicidal idea-
tion, which was represented by a positive screen for suicidal
ideation using the Yale Evaluation of Suicidality27.
Because we decided to use the ICG-R “preoccupation” item
to represent the CG test “troubling rumination” item, and to
avoid a double counting of this symptom, we chose to count
this item only once as “troubling rumination” and not also
doubly as “preoccupation”. Whether this item was counted as
“preoccupation” (in category A) or “troubling rumination” (in
category B) had no impact on results of the CG test in the pre-
sent sample. Therefore, in the present investigation, a positive
CG test indicates endorsement of at least one of three category
A items (i.e., excluding the fourth, operationally redundant,
“preoccupation” item) and at least two of eight category B
items.
DSM-5 persistent complex bereavement
disorder (PCBD) test
The proposed PCBD symptom-diagnostic test16 consists of
sixteen (four category A and twelve category B) items.
Thirteen of the sixteen PCBD test items can be, and were,
represented directly by one or more ICG-R items. Two PCBD
test items can be, and were, approximated by ICG-R items.
The PCBD test “difficulty in positive reminiscing about the
deceased” item was approximated by the ICG-R “do memories
of [the person who died] ever upset you?” item. The PCBD test
“maladaptive appraisals about oneself in relation to the
deceased or the death (e.g., self-blame)” item was approximated
by the ICG-R “do you feel at all guilty for surviving, or that it is
unfair that you should live when [the person who died] died?”
item. One PCBD test item reflects suicidal ideation and was rep-
resented by a positive screen for suicidal ideation using the Yale
Evaluation of Suicidality.
In the present study, and consistent with the DSM-5 pro-
posal16, a positive PCBD test indicates endorsement of at least
one of four category A items and at least six of twelve category
B items.
ICD-11 prolonged grief disorder (ICD-11) test
An “ICD-11 version” of the PGD symptom-diagnostic test
was constructed based on a narrative proposal for the diagnos-
tic assessment of PGD for ICD-1113. This narrative proposal
includes seven (two category A and five category B) items that
are represented directly in the ICG-R and that have been found
to be informative and unbiased in the empirical evaluation of
items presented in Prigerson et al1.
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The proposal did not include specification of a symptom
threshold, i.e. a minimum number of items (symptoms)
required to satisfy the symptom criterion. Therefore, we con-
ducted a receiver operating characteristic (ROC) analysis28 to
determine an optimum symptom threshold.
Based on the results of this analysis, in the present study, a
positive “ICD-11” test indicates endorsement of at least one of
two category A items and at least three of five category B
items. Presenting with at least three of five category B items
was associated with a sensitivity of 83.3% and a specificity of
96.2%. Presenting with at least two of five items yielded lower
specificity (sensitivity5 100%, specificity5 87.0%), while pre-
senting with at least four of five items yielded much lower sen-
sitivity (sensitivity5 60.0%, specificity5 99.6%).
Criterion standard to evaluate diagnostic properties
of tests
The criterion standard used to establish absence or pres-
ence of grief disorder in the present sample is the one devel-
oped, employed and described in detail in Prigerson et al1.
Construction of this criterion standard combined elements
of clinical judgment, reflected in raters’diagnoses of disordered
grief, with sophisticated measurement techniques. Employing
methods from item response theory29, scores from a two-
parameter logistic (2-PL) item response model (IRM) for grief
intensity – based on twelve informative unbiased ICG-R items
(symptoms) – were used to order individuals based on the
severity of their grief symptoms. An optimum minimum symp-
tom severity threshold “cutoff” score, representing a metric
boundary between cases and non-cases of disordered grief, was
then determined by varying this “cutoff” score to find a point of
maximum agreement between rater diagnoses of disordered
grief and cases identified by means of grief intensity scores.
Outcomes employed to evaluate predictive validity
of positive tests
Potential adverse outcomes following from disordered grief,
i.e. subsequent other mental disorders, suicidal ideation, func-
tional impairment, and low quality of life, were each assessed
at 12-24 months post-loss.
Mental disorders were assessed using the Structured Clini-
cal Interview for DSM-IV (SCID) Non-Patient Version30. They
included generalized anxiety disorder, post-traumatic stress
disorder and major depressive disorder. Research has sup-
ported the reliability and validity of SCID diagnoses31.
Positive responses to one or more of the four Yale Evalua-
tion of Suicidality screening questions were categorized as
having suicidal ideation.
The Established Populations for Epidemiological Studies of
the Elderly32 measured performance of activities of daily liv-
ing33 and physical functioning34. Individuals with at least
‘‘some difficulty’’ with at least one of the fourteen tasks (e.g.,
bathing) were considered functionally impaired in order to
make the measure sensitive to impairment in a highly func-
tioning sample.
Scores less than 5 (below the lowest quartile) on the Medi-
cal Outcomes Short-Form35 indicated inferior quality of life.
Statistical analysis
Pairwise agreement between tests was assessed and evaluated
using kappa statistics36,37. The diagnostic sensitivity and specif-
icity of each test was evaluated in relation to the criterion stand-
ard. The predictive validity of each symptom-diagnostic test
(evaluated between 6 to 12 months post-loss) was examined
using logistic regression models for the examined outcomes
(evaluated between 12 to 24 months post-loss) within strata
defined by the absence/presence of other mental disorders at
the time of the test. Suicidal ideation was not considered to be a
potential outcome for either the CG or PCBD tests, because each
of these tests included suicidal ideation as an item.
RESULTS
Table 1 presents the items employed in each test. Of the com-
bined total of twenty items, the PGD test uses eleven, the CG
test eighteen, the PCBD test fifteen, and the ICD-11 test seven.
CG employs two items previously reported to be biased1:
loneliness (reported to be biased with respect to gender, rela-
tionship to diseased, and time from loss) and inability to care
(reported to be biased with respect to relationship to dis-
eased). It also uses three items (envy, upsetting memories, and
drawn to places) previously reported to be uninformative1,
and one item (suicidal ideation) that might be characterized
as a correlate or consequence of prolonged, intense grief rath-
er than a symptom of grief.
PCBD employs one reportedly biased item (loneliness)1,
one reportedly uninformative item (upsetting memories)1, and
one item (suicidal ideation) better characterized as a correlate
or consequence of prolonged, intense grief1.
Neither PGD nor ICD-11 employs reportedly biased or
uninformative items, and neither employs correlates or conse-
quences of prolonged, intense grief as items.
Figure 1 displays the point prevalence rate of disorder at 6-
12 months post-loss for each test. The prevalence rates for
PGD, CG, PCBD and ICD-11 were, respectively, 11.9% (95% CI:
8.1%-15.8%), 30.2% (95% CI: 24.7%-35.7%), 14.2% (95% CI:
10.0%-18.4%), and 12.7% (95% CI: 8.7%-16.7%). There were no
statistically significant pairwise differences in prevalence rates
between PGD, PCBD and ICD-11 diagnoses (all pairwise p val-
ues >0.05), while the prevalence rate for CG diagnosis was sig-
nificantly higher than those for PGD, PCBD and ICD-11
diagnoses (all pairwise p values <0.001).
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Figure 1 Positive symptom-diagnostic test rates (N5268). PGD – prolonged grief disorder test (original version), CG – complicated grief test,
PCBD – persistent complex bereavement disorder test, ICD-11 – prolonged grief disorder test (ICD-11 proposed version)
Table 1 Items included in symptom-diagnostic tests
PGD CG PCBD ICD-11
Symptom (Item) Category Item Category Item Category Item Category Item
Yearning A 1 A 1 A 1, 2 A 1
Preoccupation A 2 B 1 A 3, 4 A 2
Part of yourself died B 1 B 11 B 2
Disbelief; Trouble accepting death B 2 B 2 B 1 B 1
Avoidance of reminders B 3 B 8 B 6
Hard to trust others B 4 B 5 B 8
Anger; Bitterness B 5 B 4 B 4 B 3
Difficulty moving on B 6 B 12 B 5
Numbness B 7 B 3 B 2
Life empty, meaningless, unfulfilling B 8 A 2 B 10
Stunned B 9 B 3 B 2
Loneliness A 2 B 9
Survivor guilt A 3 B 5 B 4
Suicidal ideation A 3 B 7
Inability to care B 5
Envious of others without loss B 5
Symptoms of deceased B 6
Hear or see deceased B 6
Memories upset you B 7 B 3
Drawn to places B 8
PGD – prolonged grief disorder test (original version), CG – complicated grief test, PCBD – persistent complex bereavement disorder test, ICD-11 – prolonged
grief disorder test (ICD-11 proposed version)
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Table 2 presents pairwise agreement between the four tests.
The PGD, PCBD and ICD-11 tests were in almost perfect
agreement with each other (with pairwise kappa ranging from
0.80 to 0.84). The CG test was in moderate agreement with
each of the other tests (with pairwise kappa ranging from 0.48
to 0.55).
Table 3 displays properties of each test, and in particular
each test’s diagnostic specificity, in relation to the criterion
standard. The PGD, PCBD and ICD-11 tests had high and com-
parable diagnostic specificity, with values of 98.3%, 95.0%, and
96.2%, respectively. The CG test had 78.6% diagnostic specific-
ity. The positive predictive value of the CG test was 37.0%, con-
siderably lower than those for the PGD (87.5%), PCBD (68.4%),
and ICD-11 (73.5%) tests. Figure 2 highlights the tradeoff
between diagnostic sensitivity and diagnostic specificity for
each of the four tests.
Tables 4 and 5 present an examination of the predictive
validity of each of the four tests in terms of four subsequent
(12-24 months post-loss) adverse outcomes, i.e., other mental
disorders (major depressive disorder, post-traumatic stress
disorder or generalized anxiety disorder), suicidal ideation,
functional impairment, and low quality of life, stratified by
absence/presence of concurrent (6-12 month post-loss) men-
tal disorders.
Among individuals without other mental disorders at 6-12
months post-loss (Table 4), positive PGD tests were signifi-
cantly associated with other mental disorders (RR54.40,
p50.048), suicidal ideation (RR53.06, p50.017), functional
impairment (RR52.08, p<0.001), and low quality of life
(RR53.40, p<0.001) at 12-24 months post-loss. Positive PCBD
tests were associated with low quality of life (RR52.68,
p50.006) at 12-24 months post-loss; and positive ICD-11 tests
were associated with suicidal ideation (RR55.04, p<0.001),
functional impairment (RR52.07, p<0.001), and low quality of
life (RR53.23, p<0.001) at 12-24 months post-loss.
Among individuals with other mental disorders at 6-12
months post-loss (Table 5), positive PGD and ICD-11 tests
were each significantly related to other mental disorders
(PGD: RR54.00, p50.0.039; ICD-11: RR54.64, p50.022) at 12-
24 months post-loss.
Positive CG tests were not significantly associated with oth-
er mental disorders, functional impairment and low quality of
life at 12-24 months post-loss, either in the absence (Table 4)
or in the presence (Table 5) of concurrent (6-12 months post-
loss) mental disorders.
DISCUSSION
This study aimed to determine whether the differences
between PGD, CG and PCBD are substantive or merely seman-
tic. Our results indicate that there is no substantive difference
between PGD and PCBD. The high level of agreement between
the PGD, PCBD and proposed ICD-11 tests; their similarly low
estimates of rate of disorder (10%) in this community popu-
lation; their comparably high levels of diagnostic specificity,
and their comparable predictive validity, all suggest that PGD
and PCBD identify the same diagnostic entity. Therefore, the
difference between PGD and PCBD is mainly semantic. In
contrast, the CG test had only moderate agreement with the
PGD, PCBD and proposed ICD-11 tests, a three-fold higher
estimate of rate of disorder (30%) in this community sample,
much poorer diagnostic specificity, and no predictive validity.
Therefore, the difference between PGD and PCBD on the one
hand, and CG on the other, is substantive.
Given that PGD and PCBD tests identify the same diagnos-
tic entity, the main difference between PGD (proposed for
adoption in ICD-11) and PCBD (introduced in DSM-5) is in
the meaning of terms used to describe this same entity. The
primary opposition is between use of the term “grief” and use
Table 3 Diagnostic sensitivity and specificity of the tests in relation to the criterion standard (N5268)
Test
True
positive
False
positive
True
negative
False
negative
Positive
predictive value
Negative
predictive value Sensitivity Specificity
PGD 28 4 234 2 87.5% 99.2% 93.3% 98.3%
CG 30 51 187 0 37.0% 100.0% 100.0% 78.6%
PCBD 26 12 226 4 68.4% 98.3% 86.7% 95.0%
ICD-11 25 9 229 5 73.5% 97.9% 83.3% 96.2%
PGD – prolonged grief disorder test (original version), CG – complicated grief test, PCBD – persistent complex bereavement disorder test, ICD-11 – prolonged
grief disorder test (ICD-11 proposed version)
Table 2 Pairwise agreement (kappa) between symptom-
diagnostic tests (N5268)
Test PGD CG PCBD ICD-11
PGD 1.00
CG 0.48 1.00
PCBD 0.80 0.55 1.00
ICD-11 0.83 0.50 0.84 1.00
PGD – prolonged grief disorder test (original version), CG – complicated grief
test, PCBD – persistent complex bereavement disorder test, ICD-11 – pro-
longed grief disorder test (ICD-11 proposed version)
Kappa values indicating almost perfect agreement are highlighted in bold prints
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of the term “bereavement” in the name of the disorder. Grief is
deep mental anguish, a process of the psyche. Bereavement is
an event, the loss of a valued loved-one due to death. Grief is a
mental entity; bereavement is not. At face value, there is no
mental entity identified in the name PCBD. How can the name
of a mental disorder not identify a mental entity?
The use of the term “complex” in the name PCBD is also
somewhat obfuscating. The PGD construct is fairly simple to
understand: individuals who are “stuck” in a state of intense
grief for a long time have PGD. If the underlying disorder is not
difficult to understand, then what is “complex” about PCBD?
The name PCBD has no clear meaning and should be aban-
doned by the DSM in favor of PGD. Even if the DSM retains this
name, researchers, clinicians and the general public should
understand that there is no substantive difference between
what the DSM calls PCBD and what the ICD calls PGD.
Disagreement between the CG test on the one hand, and
the PGD and PCBD tests on the other, combined with the CG
test’s limited specificity (78.6%), poor positive predictive value
(only 37.0%), and lack of predictive validity, suggest that the
CG test is not a valid indicator of a grief-specific disorder.
Indeed, in the current study sample, a majority of individuals
with positive CG tests had negative PGD (original version),
PCBD, and PGD (version proposed for ICD-11) tests. For this
reason, treatment studies based on samples defined in terms
of the CG may be of questionable value for a grief-specific dis-
order devoid of the CG “contaminants”.
The fact that one test includes a different set of items than
another test does not necessarily imply that the two tests are
grounded in different constructs or identify different disorders.
Tests for PGD (both the original version and the one proposed
for ICD-11) and PCBD are different but essentially equivalent
measures of a single, underlying attribute, i.e. intense grief,
and should be viewed as such. The notion that symptoms of
grief are normal but that a combination of their high intensity
and long duration is abnormal reconciles the belief that all
grief symptoms are normal, but not all grieving processes are
normal. This view, rooted in the uni-dimensionality of the
underlying grief construct, is in opposition to the notion that
some symptoms are normal and others are atypical and abnor-
mal, i.e., that pathology is expressed in the form of atypical
symptoms. Current and future alternative symptom-diagnostic
tests should be evaluated in terms of specificity, accuracy,
parsimony, and perhaps in reference to external validity;
not in terms of whether or not individual items on the
test define the pathology.
Inclusion of biased items and external correlates of PGD
(e.g., suicidal thoughts) in a criteria set for grief disorder is
questionable on psychometric and conceptual grounds. The
tests for CG and PCBD contain items that were previously
Table 4 Predictive validity of symptom-diagnostic tests in the absence of other mental disorders (N5213)
Outcome (12-24 months post-loss)
Test
Other mental
disorders Suicidal ideation
Functional
impairment Low quality of life
(6-12 months post-loss) RR p RR p RR p RR p
PGD 4.40 0.048 3.06 0.017 2.08 0.001 3.40 0.001
CG 2.90 0.101 – – 0.98 0.926 1.08 0.834
PCBD 3.52 0.097 – – 1.61 0.058 2.68 0.006
ICD-11 3.52 0.097 5.04 0.001 2.07 0.001 3.23 0.001
PGD – prolonged grief disorder test (original version), CG – complicated grief test, PCBD – persistent complex bereavement disorder test, ICD-11 – prolonged
grief disorder test (ICD-11 proposed version)
Other mental disorders considered were major depressive disorder, post-traumatic stress disorder and generalized anxiety disorder
Suicide ideation is not considered as a potential outcome for CG and PCBD, because they include suicidal ideation as an item
Statistically significant values are highlighted in bold prints
Figure 2 Symptom-diagnostic test specificity versus sensitivity (N5268).
PGD – prolonged grief disorder test (original version), CG – complicated
grief test, PCBD – persistent complex bereavement disorder test, ICD-11
– prolonged grief disorder test (ICD-11 proposed version)
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identified to be biased1. In particular, the loneliness item
included in both of these tests has been reported to be biased
not only with respect to the bereaved individual’s gender and
relationship to the deceased, but also with respect to time
from loss. Although inclusion of one or even a few biased
items in a multi-item test does not necessarily mean that the
test as a whole is biased, inclusion of biased items opens the
possibility that some groups of individuals may be misdiag-
nosed by the test due to misinterpretation of the severity of
their symptoms. For example, for bereaved spouses, loneliness
is a moderate symptom, whereas for bereaved non-spouses,
loneliness is a significantly more severe symptom of grief.
Inclusion of the loneliness item in a diagnostic test for a disor-
der of grief makes it more likely that a bereaved spouse would
be mistakenly diagnosed with that disorder due to a misinter-
pretation of the severity of his/her loneliness symptom. The
tests for CG and PCBD also include an external correlate or
consequence of PGD, i.e. suicidal thoughts, as an item. Suici-
dality may be related to grief disorder, but to include it as a
symptom that represents grief is to misunderstand what grief
is, and to confound the essence of the syndrome with its con-
sequences.
In order to include an “ICD-11 version” of a symptom-
diagnostic test for PGD in the present analysis, we needed to
specify a symptom threshold. The current narrative proposal13
for an ICD-11 version of PGD does not make this specification.
In an effort to develop diagnostic guidelines that accommo-
date flexible exercise of clinical judgment, the WHO discour-
ages methods of diagnostic assessment that employ arbitrary
thresholds and “pick lists” of items, but supports the use of
symptom thresholds that have been established empirically38.
Based on results of the ROC analysis in this study, presenting
with at least three of the proposed five accessory symptoms
represents an optimum balance of diagnostic sensitivity and
specificity in relation to our criterion standard. For this reason
we recommend that future ICD-11 research diagnostic criteria
include this “at least three of five” accessory symptom rule for
diagnosing cases of PGD. The brief, five-item “ICD-11 version”
of the PGD test also has the advantage that short tests have
over longer ones for ease of use and clinical utility21-23.
The present study evaluates the performance of symptom-
diagnostic tests for grief disorder applied within a period of 6
to 12 months post-loss. This is consistent with empirical evi-
dence that presence of enduring, intense grief beyond 6
months post-loss is predictive of subsequent mental disorders,
suicidal ideation, functional impairment, and worse quality of
life1, and with proposed diagnostic criteria for PGD1,13 and
CG15. However, it is inconsistent with the DSM-5 specification
that PCBD ought not to be diagnosed within 12 months post-
loss. In our view, this DSM-5 “time from loss” criterion is not
only arbitrary but also contrary to published empirical research
findings. In the present study, the PCBD test applied within 6 to
12months post-loss had near perfect agreement with PGD tests,
had high specificity and sensitivity with respect to our criterion
standard, and was predictive of subsequent (i.e., 12 to 24
month) worse quality of life. Based on these findings, the PCBD
symptom-diagnostic test applied within 6 to 12 months post-
loss is an empirically valid test for disorder notwithstanding the
DSM-5’s arbitrary “at least 12 months’ time from loss” criterion
for PCBD.
The present investigation has a few limitations that warrant
some consideration. One limitation is that some ICG-R items
employed in the present analysis may not have mapped exact-
ly onto some items in the proposed CG and PCBD tests. More
formal instruments to assess CG and PCBD have been intro-
duced only recently39,40. These have yet to be established and
validated in general community settings. The fact that our
proxy PCBD symptom-diagnostic test had high diagnostic spe-
cificity and sensitivity, as well as some predictive validity, sug-
gests that some imprecision in our representation of some
PCBD items did not undermine the validity of the overall PCBD
test appreciably. Given the properties of the PGD and PCBD
Table 5 Predictive validity of symptom-diagnostic tests in the presence of other mental disorders (N527)
Outcome (12-24 months post-loss)
Test
Other mental
disorders Suicidal ideation
Functional
impairment Low quality of life
(6-12 months post-loss) RR p RR p RR p RR p
PGD 4.00 0.039 2.00 0.121 0.80 0.480 1.03 0.930
CG 3.14 0.221 – – 0.86 0.655 0.86 0.655
PCBD 3.44 0.065 – – 0.69 0.228 0.88 0.697
ICD-11 4.64 0.022 1.67 0.203 0.93 0.816 1.19 0.586
PGD – prolonged grief disorder test (original version), CG – complicated grief test, PCBD – persistent complex bereavement disorder test, ICD-11 – prolonged
grief disorder test (ICD-11 proposed version)
Other mental disorders considered were major depressive disorder, post-traumatic stress disorder and generalized anxiety disorder
Suicide ideation is not considered as a potential outcome for CG and PCBD, because they include suicidal ideation as an item
Statistically significant values are highlighted in bold prints
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tests, future refinements in conceptualization and wording of
items might be expected to make marginal improvements in
what are already highly reliable and valid tests.
Another limitation of the present study is that the YBS sample
represents mainly elderly, white widows living in a relatively
small region of the US, whose spouses died primarily from natu-
ral causes. Future studies ought to examine whether and the
extent to which properties of PGD and PGBD tests and items dif-
fer with respect to the bereaved individual’s age, gender, race,
ethnicity, relationship to the deceased, and geographic or cultur-
al setting, as well as with respect to circumstances of the lost
loved-one’s death.
The present study has a number of strengths. Most impor-
tantly, the YBS was designed explicitly to evaluate diagnostic
criteria for disordered grief. YBS instrumentation included an
extensive battery of grief items sufficient to compare the four
symptom-diagnostic tests included in the present analysis.
YBS data were collected in a community sample, allowing us
to evaluate methods of diagnostic assessment that are
intended to discriminate between normal and disordered grief.
Finally, the YBS’s longitudinal design allowed us to examine
the predictive validity of positive symptom-diagnostic tests for
disordered grief.
In conclusion, the PGD, PCBD and proposed ICD-11 PGD
symptom-diagnostic tests identify a single, common diagnos-
tic entity. Therefore, the main differences between PGD and
PCBD are semantic, not substantive. The test for CG is incon-
gruous with those for PGD and PCBD, has a poorer diagnostic
specificity and no predictive validity. Clinical and scientific
communities ought to recognize that PGD and PCDB are sub-
stantively the same disorder, and ought to work toward a com-
mon understanding of that disorder and adopt useful ways to
recognize it clinically. The term “prolonged grief disorder” cap-
tures the essence of the disorder, facilitates understanding it,
and thereby supports clinical judgment in its diagnostic assess-
ment.
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